MedPath

Onsite vs. Virtual Group Fitness in Overweight/Obese Women

Not Applicable
Completed
Conditions
Overweight and Obesity
Interventions
Other: HIIT Exercise Training
Registration Number
NCT04974476
Lead Sponsor
University of Miami
Brief Summary

The purpose of this study is to compare an onsite to virtual whole-body high intensity interval training (HIIT) program on anthropometric variables, aerobic fitness measures, and vascular markers of cardiac risk in a single study of overweight and obese women.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
35
Inclusion Criteria
  • Premenopausal adult females over the age of 18 and under the age of 45 with a BMI greater than or equal to 25 and a waist circumference greater than or equal to 35 inches.
  • No medical contraindications to participation in an exercise program including major medical illnesses (i.e. cardiovascular disease, stroke, cancer, etc.)
  • Ability to provide informed consent
  • Willingness and ability to participate in an interval training in-person group fitness exercise program 3x/week for 12 weeks
Exclusion Criteria
  • Adults unable to consent or mini-mental score less than 18.
  • Individuals who are not yet adults (infants, children, teenagers)
  • Pregnant women
  • Post-menopausal women
  • Do not speak English
  • Prisoners
  • Subjects on medicines (serum glucose, insulin, weight loss medicines, beta-blockers) and having any medical pre-conditions that would interfere with one's capacity to exercise.
  • Answer "Yes" to any of the questions on the Pre-Activity Screening Questionnaire (PASQ)

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
In-person exercise training groupHIIT Exercise Trainingparticipants in this group will receive in person exercise HIIT training 3 days a week for 12 weeks
Virtual exercise training groupHIIT Exercise Trainingparticipants in this group will receive virtual exercise HIIT training 3 days a week for 12 weeks
Primary Outcome Measures
NameTimeMethod
Pulse Wave Analysis Augmentation Index (AIx)Up to 12 weeks

vascular marker of cardiac risk will be reported as AIx (%) as measured using SphygmoCor

Pulse Wave Analysis Mean Arterial Pressure (MAP)Up to 12 weeks

vascular marker of cardiac risk will be reported as MAP (mmHg) as measured using SphygmoCor

Total AdiposityUp to 12 weeks

Anthropometric measure will be reported as Total Adiposity as measured by noninvasive direct segmental multi-frequency bioelectrical impedance body composition analyzer

Pulse Wave Velocity (PWV)Up to 12 weeks

vascular marker of cardiac risk will be reported as PWV (m/s) as measured using SphygmoCor

Visceral Adipose Tissue (VAT) contentUp to 12 weeks

Anthropometric measure will be reported as VAT content as measured by noninvasive direct segmental multi-frequency bioelectrical impedance body composition analyzer

Aerobic FitnessUp to 12 weeks

Aerobic Fitness level as measured by the 20 meter shuttle run

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

University of Miami

🇺🇸

Coral Gables, Florida, United States

© Copyright 2025. All Rights Reserved by MedPath